Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

BIO-TECHNE (TECH) Gross Margin: 2009-2025

Historic Gross Margin for BIO-TECHNE (TECH) over the last 16 years, with Sep 2025 value amounting to 65.65%.

  • BIO-TECHNE's Gross Margin rose 242.00% to 65.65% in Q3 2025 from the same period last year, while for Sep 2025 it was 65.37%, marking a year-over-year decrease of 14.00%. This contributed to the annual value of 64.80% for FY2025, which is 161.00% down from last year.
  • Per BIO-TECHNE's latest filing, its Gross Margin stood at 65.65% for Q3 2025, which was up 4.66% from 62.72% recorded in Q2 2025.
  • BIO-TECHNE's Gross Margin's 5-year high stood at 8,979.75% during Q3 2022, with a 5-year trough of 62.72% in Q2 2025.
  • Moreover, its 3-year median value for Gross Margin was 66.43% (2024), whereas its average is 66.08%.
  • In the last 5 years, BIO-TECHNE's Gross Margin soared by 891,340bps in 2022 and then tumbled by 891,288bps in 2023.
  • Quarterly analysis of 5 years shows BIO-TECHNE's Gross Margin stood at 68.22% in 2021, then plummeted by 70bps to 67.52% in 2022, then tumbled by 274bps to 64.78% in 2023, then skyrocketed by 50bps to 65.27% in 2024, then soared by 242bps to 65.65% in 2025.
  • Its Gross Margin was 65.65% in Q3 2025, compared to 62.72% in Q2 2025 and 67.86% in Q1 2025.